Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 20,312 shares at $18.51 ($376K) on 2023-01-26, disclosed to the SEC on 2023-01-27.
Open-market sale of $376k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.51 | 10,156 | $188K | 50.0% |
| 2 | $18.51 | 10,156 | $188K | 50.0% |
| Total | $18.51 avg | 20,312 | $376K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |